KPC Pharmaceuticals, Inc. (600422.SS) SHH

14.03

+0.14(+1.01%)

Updated at September 29 03:00PM

Currency In CNY

Valuation

Market Cap11.94B
Enterprise Value10.43B
P/E Ratio17.15
PEG Ratio-14.23
Price/Sales Ratio1.3
Price/Book Ratio2.02
Enterprise/Revenue1.33
Enterprise/EBITDA11.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.12

Management Effectiveness

Return On Assets0.05
Return On Equity0.12

Income Statement

Revenue8.4B
Revenue/Share10.87
Gross Profit3.65B
EBITDA1.16B
Net Income648.08M
Diluted EPS0.86

Balance Sheet

Total Cash3.08B
Total Cash/Share4.08
Total Debt1.57B
Total Debt/Equity0.3
Current Ratio1.78
Book Value Per Share8.98

Price History

52-Week Change-11.43
52-Week High18.64
52-Week Low13.48
Moving Average 50 Days14.45
Moving Average 200 Days15.78

Statistics

Average Volume14.62M
Shares Outstanding756.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.14
Payout Ratio0.3
Last Split Factor2:1
Last Split DateMay 09, 2016